A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated lyme borreliosis

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 9, 2005, Pages 1069-1074

  Philipp, Mario T ^a   Wormser, Gary P ^b   Marques, Adriana R ^c   Bittker, Susan ^b   Martin, Dale S ^a   Nowakowski, John ^b   Dally, Leonard G ^d  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM ANTIBODY; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTICLE; BACTERIUM CULTURE; BORRELIA BURGDORFERI; CONVALESCENCE; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DRUG EFFICACY; ERYTHEMA CHRONICUM MIGRANS; FEMALE; FOLLOW UP; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ANTIBODY SPECIFICITY; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BORRELIA BURGDORFERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 24944535230     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.9.1069-1074.2005     Document Type: Article

References (34)

1. Bacon, R. M., B. J. Biggerstaff, M. E. Schriefer, R. D. Gilmore, M. T. Philipp, A. C. Steere, G. P. Wormser, A. R. Marques, and B. J. Johnson. 2003. Serodiagnosis of Lyme disease by kinetic ELISAs using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with two-tiered testing using whole cell lysates. J. Infect. Dis. 187:1187-1199.
2. Brown, S. T., A. Zaidi, S. A. Larsen, and G. H. Reynolds. 1985. Serological response to syphilis treatment. A new analysis of old data. JAMA 253:1296-1299.
3. Centers for Disease Control and Prevention. 2002. Lyme disease-United States, 2000. Morb. Mortal. Wkly. Rep. 51:29-31.
4. Centers for Disease Control and Prevention. 1997. Case definitions for infectious conditions under public health surveillance: Lyme disease (revised 9/96). Morb. Mortal. Wkly. Rep. 46:20-21.
5. Centers for Disease Control and Prevention. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb. Mortal. Wkly. Rep. 44:590-591.
6. Dressler, F., J. A. Whalen, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167:392-400.
7. Duncan, A., M. T. Correa, J. F. Levine, and E. B. Breitschwerdt. 2004. The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states. Vector Borne Zoonotic Dis. 4:221-229.
8. Engstrom, S. M., E. Shoop, and R. C. Johnson. 1995. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33:419-427.
9. Fiumara, N. J. 1986. Treatment of primary and secondary syphilis: serologic response. J. Am. Acad. Dermatol. 14:487-491.
10. Fritz, C. L., and A. M. Kjemtrup. 2003. Lyme borreliosis. J. Am. Vet. Med. Assoc. 223:1261-1270.
11. Halperin, J. J. 2004. Central nervous system Lyme disease. Curr. Infect. Dis. Rep. 6:298-304.
12. Heikkila, T., H. I. Huppertz, I. Seppala, H. Sillanpaa, H. Saxen, and P. Lahdenne. 2003. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J. Infect. Dis. 187:1888-1894.
13. Klempner, M. S., L. T. Hu, J. Evans, C. H. Schmid, G. M. Johnson, R. P. Trevino, D. Norton, L. Levy, D. Wall, J. McCall, M. Kosinski, and A. Weinstein. 2001. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 345: 85-92.
14. Lahdenne, P., J. Panelius, H. Saxen, T. Heikkila, H. Sillanpaa, M. Peltomaa, M. Arnez, H. I. Huppertz, and I. J. Seppala. 2003. Improved serodiagnosis of erythema migrans using novel recombinant borrelial BBK32 antigens. J. Med. Microbiol. 52:563-567.
15. Larsen, S. A., B. M. Steiner, and A. H. Rudolph. 1995. Laboratory diagnosis and interpretation of tests for syphilis. Clin. Microbiol. Rev. 8:1-21.
16. Levy, S. 2002. Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Vet. Ther. 3:420-424.
17. Levy, S., T. P. O'Connor, J. L. Hanscom, and P. Shields. 2002. Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet. Ther. 3:308-315.
18. Liang, F. T., E. Aberer, M. Cinco, L. Gern, C. M. Hu, Y. N. Lobet, M. Ruscio, P. E. Voet, Jr., V. E. Weynants, and M. T. Philipp. 2000. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J. Infect. Dis. 182:1455-1462.
19. Liang, F. T., R. H. Jacobson, R. K. Straubinger, A. Grooters, and M. T. Philipp. 2000. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 38:4160-4166.
20. Liang, F. T., A. C. Steere, A. R. Marques, B. J. B. Johnson, J. N. Miller, and M. T. Philipp. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J. Clin. Microbiol. 37:3990-3996.
21. 13a. Littman, M. P. 2003. Canine borreliosis. Vet. Clin. N. Am. Small Anim. Pract. 33:827-862.
22. 13b. Marangoni, A., M. Sparacino, V. Mondardini, F. Cavrini, E. Storni, M. Donati, R. Cevenini, and V. Sambri. 2005. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy. New Microbiol. 28:37-43.
23. 13c. Marques, A. R., D. S. Martin, and M. T. Philipp. 2002. Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine. J. Clin. Microbiol. 40:2591-2593.
24. Nowakowski, J., R. B. Nadelman, R. Sell, D. McKenna, L. F. Cavaliere, D. Holmgren, A. Gaidici, and G. P. Wormser. 2003. Long-term follow-up of patients with culture-confirmed Lyme disease. Am. J. Med. 115:91-96.
25. 14a. O'Connor, T. P., K. J. Esty, J. L. Hanscom, P. Shields, and M. T. Phillipp. 2004. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6. The conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. Clin, Diagn. Lab. Immunol. 11:458-462.
26. 14b. Panelius, J., P. Lahdenne, H. Saxen, S. A. Carlsson, T. Heikkila, M. Peltomaa, A. Lauhio, and I. Seppala. 2003. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide. J. Neurol. 250:1318-1327.
27. Peltomaa, M., G. McHugh, and A. C. Steere. 2003. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J. Infect. Dis. 187:1178-1186.
28. 16a. Peltomaa, M., G. McHugh, and A. C. Steere. 2004. The VlsE (IR6) peptide ELISA in the serodiagnosis of Lyme facial paralysis. Otol. Neurotol. 25:838-841.
29. Philipp, M. T., L. C. Bowers, P. T. Fawcett, M. B. Jacobs, F. T. Liang, A. R. Marques, P. D. Mitchell, J. E. Purcell, M. S. Ratterree, and R. K. Straubinger. 2001. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borreliaburgdorferi infection in experimental animals and in humans. J. Infect. Dis. 184:870-878.
30. 6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis. J. Clin. Microbiol. 41:4955-4960.
31. Steere, A. C. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
32. Steere, A. C., R. E. Levin, P. J. Molloy, R. A. Kalish, J. H. Abraham III, N. Y. Liu, and C. H. Schmid. 1994. Treatment of Lyme arthritis. Arthritis Rheum. 37:878-888.
33. 19a. Stone, E. G., E. H. Lacombe, and P. W. Rand. 2005. Antibody testing and Lyme disease risk. Emerg. Infect. Dis. 11:722-724.
34. Wormser, G. P., R. B. Nadelman, R. J. Dattwyler, D. T. Dennis, E. D. Shapiro, A. C. Steere, T. J. Rush, D. W. Rahn, P. K. Coyle, D. H. Persing, D. Fish, and B. J. Luft. 2000. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin. Infect. Dis. 31(Suppl. 1):1-14.